MedTrace Logo

Late Stent Strut Apposition and Coverage After Drug-Eluting Stent Implantation by OCT in Patients With AMI

NCT02770651 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2018-01-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the incidence of late incomplete stent apposition (ISA) and un-coverage by optical coherence tomography (OCT) following everolimus-eluting stent (EES) with bioabsorbable polymer (SYNERGY™, Boston Scientific,Nattick, MA, USA) versus zotarolimus-eluting stent (ZES) with permanent polymer(Resolute Onyx™, Medtronic, Santa Rosa, CA, USA) implantation in patients with AMI at 12 months.

Conditions

Interventions

DEVICE

Everolimus-Eluting stent

Everolimus-Eluting stent with bioabsorbable polymer

DEVICE

Zotarolimus-Eluting stent

Zotarolimus-Eluting stent with permanent polymer

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Seung-Ho Hur, Postdoctoral · Keimyung University Dongsan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02770651 on ClinicalTrials.gov